Insights

Recent Acquisitions Roivant Sciences has been actively acquiring companies, such as Dermavant Sciences and partnering with industry giants like Bayer AG. Leveraging these recent acquisitions and collaborations can provide sales opportunities through cross-selling and expanding product offerings to a wider customer base.

Innovative Treatment Portfolio Being recognized as a 'Top Pick' for its innovative portfolio of treatments indicates strong market appeal. Leveraging this reputation to highlight unique treatment options and the company's track record in drug development can open doors for sales discussions with healthcare providers and institutions seeking cutting-edge solutions.

Strategic Investments Roivant Sciences' investments in companies like Zest Health demonstrate a commitment to fostering innovation in healthcare. Exploring partnership opportunities with these invested companies can lead to sales collaboration, offering complementary products or services to meet evolving market demands.

Technology Integration By utilizing advanced technologies like Amazon Web Services and Drupal Multisite, Roivant is positioned to deliver efficient and scalable solutions. Highlighting the technological capabilities can differentiate the company in the market and attract tech-savvy clients looking for cutting-edge biotech and healthcare technology partners.

Revenue Growth Potential With a revenue range of $50-100 million and significant funding of $1.3 billion, Roivant Sciences shows potential for growth. Capitalizing on this financial stability and growth trajectory, sales professionals can target strategic partnerships, licensing agreements, and product sales to drive revenue growth for both parties.

Roivant Sciences Tech Stack

Roivant Sciences uses 8 technology products and services including Asana, DataTables, PWA, and more. Explore Roivant Sciences's tech stack below.

  • Asana
    Issue Trackers
  • DataTables
    Javascript Libraries
  • PWA
    Miscellaneous
  • Office 365
    Office Suites
  • Yoast SEO
    Search Engines
  • X-XSS-Protection
    Security
  • Adobe Tag Manager
    Tag Management
  • Tailwind CSS
    UI Frameworks

Media & News

Roivant Sciences's Email Address Formats

Roivant Sciences uses at least 1 format(s):
Roivant Sciences Email FormatsExamplePercentage
First.Last@roivant.comJohn.Doe@roivant.com
83%
Last.First@roivant.comDoe.John@roivant.com
11%
Last@roivant.comDoe@roivant.com
5%
First@roivant.comJohn@roivant.com
1%

Frequently Asked Questions

Where is Roivant Sciences's headquarters located?

Minus sign iconPlus sign icon
Roivant Sciences's main headquarters is located at Viaduktstrasse 8 Basel, Basel-Stadt 4051 CH. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Roivant Sciences's stock symbol?

Minus sign iconPlus sign icon
Roivant Sciences is a publicly traded company; the company's stock symbol is ROIVW.

What is Roivant Sciences's official website and social media links?

Minus sign iconPlus sign icon
Roivant Sciences's official website is roivant.com and has social profiles on LinkedIn.

How much revenue does Roivant Sciences generate?

Minus sign iconPlus sign icon
As of May 2025, Roivant Sciences's annual revenue reached $75M.

What is Roivant Sciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Roivant Sciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Roivant Sciences have currently?

Minus sign iconPlus sign icon
As of May 2025, Roivant Sciences has approximately 258 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: M. G.Chief Executive Officer: C. M.Chief Financial Officer: R. P.. Explore Roivant Sciences's employee directory with LeadIQ.

What industry does Roivant Sciences belong to?

Minus sign iconPlus sign icon
Roivant Sciences operates in the Biotechnology Research industry.

What technology does Roivant Sciences use?

Minus sign iconPlus sign icon
Roivant Sciences's tech stack includes AsanaDataTablesPWAOffice 365Yoast SEOX-XSS-ProtectionAdobe Tag ManagerTailwind CSS.

What is Roivant Sciences's email format?

Minus sign iconPlus sign icon
Roivant Sciences's email format typically follows the pattern of . Find more Roivant Sciences email formats with LeadIQ.

How much funding has Roivant Sciences raised to date?

Minus sign iconPlus sign icon
As of May 2025, Roivant Sciences has raised $1.3B in funding. The last funding round occurred on Oct 19, 2018 for $200M.

When was Roivant Sciences founded?

Minus sign iconPlus sign icon
Roivant Sciences was founded in 2014.
Roivant Sciences

Roivant Sciences

Biotechnology ResearchBasel-Stadt, Switzerland201-500 Employees

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology.

The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. 

In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.

Section iconCompany Overview

Headquarters
Viaduktstrasse 8 Basel, Basel-Stadt 4051 CH
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ROIVW
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconFunding & Financials

  • $1.3B

    Roivant Sciences has raised a total of $1.3B of funding over 2 rounds. Their latest funding round was raised on Oct 19, 2018 in the amount of $200Mas a equity financing.

  • $50M$100M

    Roivant Sciences's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $1.3B

    Roivant Sciences has raised a total of $1.3B of funding over 2 rounds. Their latest funding round was raised on Oct 19, 2018 in the amount of $200Mas a equity financing.

  • $50M$100M

    Roivant Sciences's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.